Sees FY25 gross margin mid 80%; non-GAAP operating expenses $380M-$400M; GAAP net income positive during 2H25.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FOLD:
- FOLD Earnings this Week: How Will it Perform?
- Starbucks downgraded, Oracle initiated: Wall Street’s top analyst calls
- Amicus upgraded to Overweight from Equal Weight at Morgan Stanley
- Amicus Therapeutics Advances Pediatric Fabry Disease Study with Migalastat
- Amicus Therapeutics Advances Pompe Disease Research with New Observational Study